Isoniazid in the treatment of chronic lupus erythematosus.

B. Appel; G. R. Baler; E. Dougherty

DOI:10.1001/ARCHDERM.1953.01540100057009

Corpus ID: 21854156

Isoniazid in the treatment of chronic lupus erythematosus.

@article{Appel1953IsoniazidIT,
  title={Isoniazid in the treatment of chronic lupus erythematosus.},
  author={B. Appel and G. R. Baler and E. Dougherty},
  journal={A.M.A. archives of dermatology and syphilology},
  year={1953},
  volume={68 4},
  pages={
          417-20
        }
}

B. Appel, G. R. Baler, E. Dougherty

Published 1953

Medicine

A.M.A. archives of dermatology and syphilology

CHRONIC lupus erythematosus is notoriously resistant to treatment. Until 1951, bismuth, gold, and arsenic were the principal systemic agents; second choices were suramin sodium (Naphuride), 1 quinine, crude liver extract, and vitamin E; third choice was local destruction, usually with carbon dioxide. In 1951, quinacrine (Mepacrine, Atabrine) was reported by Page 2 to have produced excellent results, and personal reports to us by several dermatologists indicate an increasing confirmation of good… CONTINUE READING

View on PubMed